Two Sigma Investments, LP Profound Medical Corp. Transaction History

Two Sigma Investments, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$13.6 - $17.88 $253,191 - $332,871	-18,617 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$16.0 - $20.59 $527,568 - $678,914	-32,973 Reduced 63.91%	18,617 $305,000
Q1 2021 May 17, 2021	SELL	$19.16 - $28.09 $80,127 - $117,472	-4,182 Reduced 7.5%	51,590 $1.04 Million
Q4 2020 Feb 16, 2021	BUY	$16.4 - $22.9 $214,249 - $299,165	13,064 Added 30.59%	55,772 $1.15 Million
Q3 2020 Nov 16, 2020	BUY	$14.05 - $18.13 $600,047 - $774,296	42,708 New	42,708 $753,000
Q2 2020 Aug 14, 2020	SELL	$9.41 - $16.94 $136,445 - $245,630	-14,500 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$6.88 - $19.7 $99,760 - $285,650	14,500 New	14,500 $141,000

8.93M

1.2K

Ticker PROF
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,851,300
Market Cap $146M
Description
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.